[Changes induced with ergot alkaloids in the effects of cerebral ischemia on evoked potentials in the cat].
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism / Q000503:physiopathology*; D002415:Cats; D004877:Ergoloid Mesylates / Q000494:pharmacology; D004876:Ergot Alkaloids / Q000494:pharmacology*; D004878:Ergotamine / Q000494:pharmacology; D005071:Evoked Potentials; D002546:Ischemic Attack, Transient / Q000378:metabolism / Q000503:physiopathology*; D007545:Isoproterenol / Q000494:pharmacology; D009530:Nicergoline / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology
D004876:Ergot Alkaloids; D000804:Angiotensin II; D004877:Ergoloid Mesylates; D010208:Papaverine; D009530:Nicergoline; D007545:Isoproterenol; D004878:Ergotamine; D009638:Norepinephrine
Modifications, par les alcaloides de l'ergot de seigle, des effets de l'ischemie cerebrale sur les potentiels evoques chez le chat